Global Blood Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Global Blood Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Global Blood Therapeutics Inc Strategy Report
- Understand Global Blood Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Global Blood Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| ZA201703791B | Grant | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | A61K31/40; A61K31/4025; A61K31/4439; A61K31/445; A61K31/5375; A61P11/00; A61P17/02; A61P25/28; A61P35/00; A61P43/00; A61P7/00; A61P7/06; C07C271/16; C07D207/08; C07D207/34; C07D207/48; C07D211/16; C07D211/20; C07D211/22; C07D211/30; C07D211/60; C07D211/78; C07D213/81; C07D241/04; C07D241/42; C07D265/30; C07D279/12; C07D295/16; C07D309/08; C07D309/28; C07D333/38; C07D335/02; C07D401/06; C07D401/12; C07D403/06; C07D403/12 | August 31, 2022 |
| HUS2200037I1 | Application | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | A61K31/192; A61K31/235; A61K31/41; A61K31/416; A61K31/437; A61K31/4406; A61K31/4439; A61K31/445; A61K31/47; A61K31/4985; A61P1/00; A61P1/04; A61P11/00; A61P17/00; A61P17/02; A61P25/00; A61P25/28; A61P31/00; A61P31/14; A61P35/00; A61P43/00; A61P7/00; A61P7/06; A61P9/00; A61P9/10; C07C65/24; C07C65/30; C07C69/736; C07C69/76; C07D211/62; C07D213/30; C07D213/80; C07D215/14; C07D231/56; C07D257/04; C07D401/04; C07D471/04; C07D487/04; Y02P20/55 | August 28, 2022 |
| US20220267337A1 | Application | PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS | C07D487/04 | August 25, 2022 |
| EP4046988A1 | Application | 2-FORMYL-3-HYDROXYPHENYLOXYMETHYLVERBINDUNGEN, DIE HÄMOGLOBIN MODULIEREN KÖNNEN | A61K31/4545; A61K31/5377; A61K31/541; A61P7/06; C07D207/08; C07D211/22; C07D265/30; C07D279/12; C07D401/06; C07D401/10; C07D401/14; C07D403/06; C07D413/06; C07D417/06 | August 24, 2022 |
| WO2022170200A1 | Application | 1-(2-SULFONYL-2,6-DIHYDROPYRROLO[3,4-C]PYRAZOL-5(4H)-YL]-ETHANONE DERIVATIVES AS PYRUVATE KINASE (PKR) AND PKM2 ACTIVATORS FOR THE TREATMENT OF SICKLE CELL DISEASE | A61P7/06; C07D487/04 | August 11, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer